Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

GSK plc DRC (GS70y)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
36.800 -0.200    -0.54%
03:15:34 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US37733W1053 
S/N:  A3DMHS
  • Volume: 0
  • Bid/Ask: 37.000 / 37.400
  • Day's Range: 36.800 - 36.800
GSK plc DRC 36.800 -0.200 -0.54%

GSK plc F Company Profile

 
Get an in-depth profile of GSK plc DRC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

70212

Equity Type

DRC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Contact Information

Address 980 Great West Road Middlesex
Brentford, TW8 9GS
United Kingdom
Phone 44 20 8047 5000
Fax -
Web www.gsk.com

Top Executives

Name Age Since Title
Emma Natasha Walmsley 53 2011 CEO & Director
Jonathan Richard Symonds 64 2019 Non-Executive Chairman
Urs Rohner 64 2015 Independent Non-Executive Director
Charles A. Bancroft 63 2020 Senior Independent Non-Executive Director
Anne C. Beal 61 2021 Independent Non-Executive Director
Harry C. Dietz 65 2022 Independent Non-Executive Director
Elizabeth McKee Anderson 66 2022 Independent Non-Executive Director
Jesse L. Goodman 71 2016 Independent Non-Executive Director
Julie Brown 61 2023 CFO & Executive Director
Hal V. Barron 60 2018 Non-Executive Director
Vishal Sikka 56 2022 Independent Non-Executive Director
Wendy Becker 58 2023 Independent Non-Executive Director
Jeannie T. Lee - 2024 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

GSK Comments

Write your thoughts about GSK plc F
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
William Hineser
William Hineser Feb 28, 2024 2:07PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Most large international pharm companies are good long term investments.
Reply
0 0
Report
William Hineser
William Hineser Feb 05, 2024 9:45AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Finally, some improvement, with reservations.
Reply
0 0
Report
William Hineser
William Hineser Nov 14, 2023 10:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
One of the few pharm companies not improving. Why?
Reply
0 0
Report
Arth Dlg
Arth Dlg Apr 27, 2023 9:32AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
RSV approval is a great announcement. I am buying :)
Reply
1 0
Report
Jeff Chui
Jeff Chui Sep 15, 2022 9:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy here 31.2 Someone just bought 700k shares ($21million) pre market
Reply
2 0
Report
daniel daniel
daniel daniel Sep 15, 2022 9:05AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
yes i entered at the same price, went against my rule of waiting the SPY to fall to the support level which would be around 365, i hope it was not a trick to get some new hodlers .... yet i feel relaxed because of the high dividend
Reply
2 0
Report
peter pan
peter pan Aug 18, 2022 7:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
GSK will fall to $25 level. Mark my words.
Reply
4 8
Report
Jay Ow
Jay Ow Aug 18, 2022 7:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
They all can do whatever after covid fraud. I do not want see any of these MED stocks at all for me and for many others they are just Murderers
Reply
0 1
Report
Dan Dc
DanDc Aug 17, 2022 10:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought @ 34.36
Reply
1 0
Report
Jaeyong Lee
Jaeyong Lee Aug 17, 2022 10:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought @33.07
Reply
1 0
Report
Dan Dc
DanDc Aug 17, 2022 10:43AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
i bought for long term , now the stimulus in Europe will pump this stock.
Reply
0 1
Report
Patricio Garnica
Patricio Garnica Aug 11, 2022 1:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
is It a good entry point?
Reply
5 0
Report
Mo Ali
Av8er31 Aug 11, 2022 1:16PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Absolutely.
Reply
1 1
Report
William Hineser
William Hineser Aug 11, 2022 10:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Glad I don't have many shares.
Reply
0 0
Report
True Thao
True Thao Aug 11, 2022 10:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
🤣🤣🤣
Reply
0 0
Report
Jonathan Sanders
Jonathan Sanders Aug 03, 2022 9:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
GSK recently struck a deal to purchase Sierra Oncology (SRRA) for a total of $1.9 billion to bolster its oncology offerings.... what we think about this acquisition
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email